These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2422479)

  • 1. Impairment of renal function due to sulphinpyrazone after coronary artery bypass surgery: a prospective double-blind study.
    Boelaert J; Lijnen P; Robbens E; Rocher A; Daneels R; Schurgers M; Amery A
    J Cardiovasc Pharmacol; 1986; 8(2):386-91. PubMed ID: 2422479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in renal function due to sulphinpyrazone treatment early after myocardial infarction.
    Lijnen P; Boelaert J; van Eeghem P; Daneels R; Schurgers M; de Jaegere P; van der Stichele E; Vincke J; Fagard R; Verschueren LJ; Amery A
    Clin Nephrol; 1983 Mar; 19(3):143-6. PubMed ID: 6340878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aspirin on renal function and the prostaglandin-kallikrein systems early after myocardial infarction.
    Lijnen P; Boelaert J; Van Eeghem P; Daneels R; Schurgers M; De Jaegere P; Van der Stichele E; Vincke J; Verschueren LJ; Amery A
    J Cardiovasc Pharmacol; 1984; 6(3):455-9. PubMed ID: 6202972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulphinpyrazone and renal function following myocardial infarction.
    Choudhury SL; Taylor SH; Wieringa G; Swaminathan R; Morgan DB
    Eur J Clin Pharmacol; 1983; 24(6):747-50. PubMed ID: 6884411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin-kallikrein-renin system during acute sulphinpyrazone administration in healthy volunteers.
    Verschueren LJ; Boelaert J; Daneels R; Schurgers M; Van Eeghem P; Lijnen P; Amery A
    Methods Find Exp Clin Pharmacol; 1982; 4(6):425-9. PubMed ID: 6755104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulphinpyrazone in acute myocardial infarction: studies on cardiac rhythm and renal function.
    Wilcox RG; Richardson D; Hampton JR; Mitchell JR; Banks DC
    Br Med J; 1980 Aug; 281(6239):531-4. PubMed ID: 7000264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute renal effects of sulindac and indomethacin in chronic renal failure.
    Berg KJ; Talseth T
    Clin Pharmacol Ther; 1985 Apr; 37(4):447-52. PubMed ID: 3884224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of intravenous acetylsalicylic acid and sodium salicylate on human renal function and lithium clearance.
    Reimann IW; Golbs E; Fischer C; Frölich JC
    Eur J Clin Pharmacol; 1985; 29(4):435-41. PubMed ID: 3912188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of norepinephrine and renal denervation on renal PGE2 and kallikrein in rats.
    Diz DI; Baer PG; Nasjletti A
    Am J Physiol; 1981 Nov; 241(5):F477-81. PubMed ID: 6946712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study.
    Balkanay OO; Goksedef D; Omeroglu SN; Ipek G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):209-14. PubMed ID: 25392341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelations of the renal kallikrein-kinin system and renal prostaglandins in the conscious rat. Influence of mineralocorticoids.
    Nasjletti A; McGiff JC; Colina-Chourio J
    Circ Res; 1978 Nov; 43(5):799-807. PubMed ID: 309362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARTA: AT1-receptor blocker therapy in patients undergoing coronary artery bypass grafting.
    Flesch M; Knipp S; Kessler G; Geissler HJ; Massoudy P; Wilhelm H; Philipp T; Erdmann E
    Clin Res Cardiol; 2009 Jan; 98(1):33-43. PubMed ID: 18853093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sulfinpyrazone on renal function and prostaglandin formation in man.
    Rosenkranz B; Fejes-Tóth G; Diener U; Frölich JC
    Nephron; 1985; 39(3):237-43. PubMed ID: 3883211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sulindac and naproxen in patients with chronic glomerular disease.
    Kamper AL; Strandgaard S; Christensen P; Svendsen UG
    Scand J Rheumatol Suppl; 1986; 62():26-31. PubMed ID: 3541165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary excretion of PGE2 and renal function in acute myocardial infarction].
    Bernardi P; Bastagli L; Ghezzi F; Grimaldi R; Cavazza M; Minelli C; Ventura C; Clò C; Capelli M; Vitali A
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1827-32. PubMed ID: 6596114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravenous aspirin on prostaglandin synthesis and kidney function in intensive care patients.
    Bock HA; Frölich JC; Ritz R; Brunner FP
    Nephrol Dial Transplant; 1986; 1(3):164-9. PubMed ID: 3110670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prostaglandin E2 excretion with oral kallikrein treatment in hypertensive and normotensive subjects.
    Muller HM; Overlack A; Stumpe KO; Kollock R; Ressel C
    Adv Exp Med Biol; 1983; 156 (Pt B)():1005-9. PubMed ID: 6574693
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal kallikrein excretion in alcoholic cirrhosis. Relationship to other vasoactive systems.
    Zipser RD; Kerlin P; Hoefs JC; Zia P; Barg A
    Am J Gastroenterol; 1981 Mar; 75(3):183-7. PubMed ID: 7015845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial.
    Kulka PJ; Tryba M; Zenz M
    Crit Care Med; 1996 Jun; 24(6):947-52. PubMed ID: 8681596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.